Key result
Exercise testing for ED patients with chest pain demonstrated high negative predictive accuracy, with only 5 of 168 (3.0%) patients with negative tests developing angina over 20 months.
Why the study?
Does exercise testing following cardiologist evaluation accurately exclude angina and reduce costs compared to sestamibi scanning in ED patients with chest pain?
Cohort (n=239)
Does exercise testing following cardiologist evaluation accurately exclude angina and reduce costs compared to sestamibi scanning in ED patients with chest pain?
Exercise testing is a safe, cost-effective initial screening tool with high negative predictive value for excluding angina in ED patients with chest pain.
No takes yet. Share an insight, caveat, or question.
Supports exercise testing to exclude angina after ED cardiologist evaluation; leaves open randomized confirmation of safety and costs.
Senaratne et al. (1999) conducted a cohort in Chest pain (n=239). Exercise testing vs. Sestamibi scanning was evaluated on Future coronary events (angina diagnosis) among patients with negative tests. Exercise testing for ED patients with chest pain demonstrated high negative predictive accuracy, with only 5 of 168 (3.0%) patients with negative tests developing angina over 20 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: